Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression
Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression
Brainstorm Cell Therapeutics宣布发表经同行评审的肌肉和神经三期生物标志物数据，这表明Debamestrocel或NuroWN可能会影响肌萎缩性侧索硬化症中预测疾病进展的关键生物标志物
Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression
Brainstorm Cell Therapeutics宣布发表经同行评审的肌肉和神经三期生物标志物数据，这表明Debamestrocel或NuroWN可能会影响肌萎缩性侧索硬化症中预测疾病进展的关键生物标志物
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。